Back to search

Article

Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib

2024-10-23

Abstract excerpt

<title>Abstract</title> <p>Juvenile dermatomyositis (JDM) is a rare autoimmune disorder affecting children, mainly characterized by skin rash and muscle weakness (1). Anti-MDA5 antibody-positive JDM represents a distinct phenotype of disease with a high risk of developing life-threatening progressive interstitial lung disease (ILD)(2). The pivotal role of the type I interferon (IFN) pathway in the pathogenesis of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd79564d-6744-5e38-9edd-bb2c51f0d5e3
DOI
10.21203/rs.3.rs-4973421/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibDOI 10.21203/rs.3.rs-4973421/v1
Select a neighboring publication to make it the new centre.